Hecker Andreas, Schneck E, Röhrig R, Roller F, Hecker B, Holler J, Koch C, Hecker M, Reichert M, Lichtenstern C, Krombach G A, Padberg W, Weigand M A
Department of General and Thoracic Surgery, University Hospital Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany.
Department of Anesthesiology, Surgical Intensive Care Medicine and Pain Therapy, University Hospital Giessen, Rudolf-Buchheim-Street 7, 35392 Giessen, Germany.
World J Emerg Surg. 2015 Nov 6;10:54. doi: 10.1186/s13017-015-0047-0. eCollection 2015.
An abdominal inflammatory focus is the second most often source of sepsis with a high risk of death in surgical intensive care units. By establishing evidence-based bundled strategies the surviving sepsis campaign provided an optimized rapid and continuous treatment of these emergency patients. Hereby the hospital mortality decreased from 35 to 30 %. Sepsis treatment is based on three major therapeutic elements: surgical treatment (source control), antiinfective treatment, and supportive care. The international guidelines of the surviving sepsis campaign were updated recently and recommend rapid diagnosis of the infection and source control within the first 12 h after the diagnosis (grade 1c). Interestingly this recommendation is mainly based on studies on soft tissue infections.
In this retrospective analysis 76 septic patients with an intraabdominal inflammatory focus were included. All patients underwent surgery at different time-points after diagnosis.
With 80 % patients of the early intervention group had an improved overall survival (vs. 73 % in the late intervention group).
Literature on the time dependency of early source control is rare and in part contradicting. Results of this pilot study reveal that immediate surgical intervention might be of advantage for septic emergency patients. Further multi-center approaches will be necessary to evaluate, whether the TTI has any impact on the outcome of septic patients with intestinal perforation.
腹部炎症病灶是脓毒症的第二大常见来源,在外科重症监护病房中具有很高的死亡风险。通过制定基于证据的综合策略,脓毒症存活行动为这些急诊患者提供了优化的快速和持续治疗。据此,医院死亡率从35%降至30%。脓毒症治疗基于三个主要治疗要素:手术治疗(源头控制)、抗感染治疗和支持治疗。脓毒症存活行动的国际指南最近进行了更新,建议在诊断后的前12小时内快速诊断感染并进行源头控制(1c级)。有趣的是,这一建议主要基于对软组织感染的研究。
在这项回顾性分析中,纳入了76例有腹部炎症病灶的脓毒症患者。所有患者在诊断后的不同时间点接受了手术。
早期干预组80%的患者总体生存率有所提高(晚期干预组为73%)。
关于早期源头控制时间依赖性的文献很少,且部分相互矛盾。这项初步研究的结果表明,立即进行手术干预可能对脓毒症急诊患者有益。需要进一步的多中心研究来评估,时间窗干预是否对肠穿孔脓毒症患者的预后有任何影响。